Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Immunological memory to hyperphosphorylated tau in asymptomatic individuals.

Pascual G, Wadia JS, Zhu X, Keogh E, Kükrer B, van Ameijde J, Inganäs H, Siregar B, Perdok G, Diefenbach O, Nahar T, Sprengers I, Koldijk MH, der Linden EC, Peferoen LA, Zhang H, Yu W, Li X, Wagner M, Moreno V, Kim J, Costa M, West K, Fulton Z, Chammas L, Luckashenak N, Fletcher L, Holland T, Arnold C, Anthony Williamson R, Hoozemans JJ, Apetri A, Bard F, Wilson IA, Koudstaal W, Goudsmit J.

Acta Neuropathol. 2017 May;133(5):767-783. doi: 10.1007/s00401-017-1705-y. Epub 2017 Mar 24.

2.

Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.

Shekhar S, Kumar R, Rai N, Kumar V, Singh K, Upadhyay AD, Tripathi M, Dwivedi S, Dey AB, Dey S.

PLoS One. 2016 Jul 26;11(7):e0159099. doi: 10.1371/journal.pone.0159099. eCollection 2016.

3.

Multiple signaling factors and drugs alleviate neuronal death induced by expression of human and zebrafish tau proteins in vivo.

Wu BK, Yuan RY, Lien HW, Hung CC, Hwang PP, Chen RP, Chang CC, Liao YF, Huang CJ.

J Biomed Sci. 2016 Feb 6;23:25. doi: 10.1186/s12929-016-0237-4.

4.

Melatonin Therapy in Patients with Alzheimer's Disease.

Cardinali DP, Vigo DE, Olivar N, Vidal MF, Brusco LI.

Antioxidants (Basel). 2014 Apr 10;3(2):245-77. doi: 10.3390/antiox3020245. Review.

5.

Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.

Simon MJ, Iliff JJ.

Biochim Biophys Acta. 2016 Mar;1862(3):442-51. doi: 10.1016/j.bbadis.2015.10.014. Epub 2015 Oct 22. Review.

6.

Glycogen Synthase Kinase 3β-mediated Phosphorylation in the Most C-terminal Region of Protein Interacting with C Kinase 1 (PICK1) Regulates the Binding of PICK1 to Glutamate Receptor Subunit GluA2.

Yagishita S, Murayama M, Ebihara T, Maruyama K, Takashima A.

J Biol Chem. 2015 Dec 4;290(49):29438-48. doi: 10.1074/jbc.M114.619668. Epub 2015 Oct 15.

7.

Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β.

Jiang J, Wang ZH, Qu M, Gao D, Liu XP, Zhu LQ, Wang JZ.

Sci Rep. 2015 Jun 29;5:11765. doi: 10.1038/srep11765.

8.

Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases.

Alexander AG, Marfil V, Li C.

Front Genet. 2014 Sep 5;5:279. doi: 10.3389/fgene.2014.00279. eCollection 2014. Review.

9.

Immunodetection of Tau microtubule-associated protein in human sperm and testis.

Sigala J, Jumeau F, Caillet-Boudin ML, Sergeant N, Ballot C, Rigot JM, Marcelli F, Tardivel M, Buée L, Mitchell V.

Asian J Androl. 2014 Nov-Dec;16(6):927-8. doi: 10.4103/1008-682X.136446. No abstract available.

10.

Prediction of miRNA-mRNA associations in Alzheimer's disease mice using network topology.

Noh H, Park C, Park S, Lee YS, Cho SY, Seo H.

BMC Genomics. 2014 Aug 3;15:644. doi: 10.1186/1471-2164-15-644.

11.

GSK-3β, a pivotal kinase in Alzheimer disease.

Llorens-Martín M, Jurado J, Hernández F, Avila J.

Front Mol Neurosci. 2014 May 21;7:46. doi: 10.3389/fnmol.2014.00046. eCollection 2014. Review.

12.

Tau protein modifications and interactions: their role in function and dysfunction.

Mietelska-Porowska A, Wasik U, Goras M, Filipek A, Niewiadomska G.

Int J Mol Sci. 2014 Mar 18;15(3):4671-713. doi: 10.3390/ijms15034671. Review.

13.

The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease.

Grimm MO, Zimmer VC, Lehmann J, Grimm HS, Hartmann T.

Biomed Res Int. 2013;2013:814390. doi: 10.1155/2013/814390. Epub 2014 Feb 19. Review.

14.

Linking traumatic brain injury to chronic traumatic encephalopathy: identification of potential mechanisms leading to neurofibrillary tangle development.

Lucke-Wold BP, Turner RC, Logsdon AF, Bailes JE, Huber JD, Rosen CL.

J Neurotrauma. 2014 Jul 1;31(13):1129-38. doi: 10.1089/neu.2013.3303. Epub 2014 Apr 11. Review.

15.

Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias.

Murray ME, Kouri N, Lin WL, Jack CR Jr, Dickson DW, Vemuri P.

Alzheimers Res Ther. 2014 Jan 2;6(1):1. doi: 10.1186/alzrt231. eCollection 2014. Review.

16.

LIS1 and DCX: Implications for Brain Development and Human Disease in Relation to Microtubules.

Reiner O.

Scientifica (Cairo). 2013;2013:393975. doi: 10.1155/2013/393975. Epub 2013 Mar 17. Review.

17.

Brain site-specific proteome changes in aging-related dementia.

Manavalan A, Mishra M, Feng L, Sze SK, Akatsu H, Heese K.

Exp Mol Med. 2013 Sep 6;45:e39. doi: 10.1038/emm.2013.76.

18.

Oxidative stress and the pathogenesis of Alzheimer's disease.

Zhao Y, Zhao B.

Oxid Med Cell Longev. 2013;2013:316523. doi: 10.1155/2013/316523. Epub 2013 Jul 25. Review.

19.

Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo.

Hristodorov D, Mladenov R, Pardo A, Pham AT, Huhn M, Fischer R, Thepen T, Barth S.

Br J Cancer. 2013 Sep 17;109(6):1570-8. doi: 10.1038/bjc.2013.457. Epub 2013 Aug 13.

20.

Antisense reduction of tau in adult mice protects against seizures.

DeVos SL, Goncharoff DK, Chen G, Kebodeaux CS, Yamada K, Stewart FR, Schuler DR, Maloney SE, Wozniak DF, Rigo F, Bennett CF, Cirrito JR, Holtzman DM, Miller TM.

J Neurosci. 2013 Jul 31;33(31):12887-97. doi: 10.1523/JNEUROSCI.2107-13.2013.

Supplemental Content

Support Center